HUC2-676-R
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for HUC2-676-R, covering 2026-01-13 to 2026-01-13. Get the full timeline:
Most recent: Clinical Trial Update: Study to Compare and Evaluate the Safety and Pharmacokinetics After Subcutaneous Injection of HUC2-676 or HUC2-676-R in Healthy Adult Subjects [Phase 1]